EU Panel Backs Risankizumab (Skyrizi) for Plaque Psoriasis
The interleukin-23 inhibitor is for treatment of moderate to severe plaque psoriasis in adults who are candidates for systemic therapy. International Approvals …read more
Miami OBGYN Society
A Membership Organization of South Florida Obstetrician-Gynecologists
